Starlet Johnson Leads Communications at the Food and Drug Administration

The Food and Drug Administrations’ Center for Device and Radiological Health named Starlet Johnson as their Director for the Office of Communications and Education. 

As a Senior Executive Starlet is responsible for serving as the principal advisor to the Center Director, Dr. Jeffrey Shuren, and other key officials on medical device issues pertaining to internal and external communication and education activities. She will participate in Center and Agency-level decisions, policy development, nationwide program execution and oversee and guide a team of 150.

Starlet spent 20 years as a healthcare communications professional, leading internal, external and education communications in various capacities. She has spent the last 12 years at Cigna, building capacity and internal processes for the organization. Alongside her team, she  transformed Cigna’s National Provider Communications Center of Excellence into a scalable, high-performing team that doubled support for various lines of business, while boosting team productivity by 557% in a 5-year period.

The Food and Drug Administration (FDA) is a Federal scientific regulatory agency with the legislated responsibility to protect and promote the public health of the Nation’s 245 million consumers. FDA is responsible for the health and safety of food and food additives, drugs, biological products, cosmetics, medical devices, and ionizing and non-ionizing radiation-emitting products and substances. Through its regulatory role, FDA national programs directly affect and profoundly impact multi-billion-dollar industries, in addition to protecting the public health of hundreds of millions of American consumers. 

The mission of the Center for Devices and Radiological Health (CDRH) is to protect and promote public health. CDRH assures that patients and providers have timely and continued access to safe, effective, and high-quality medical devices and safe radiation- emitting products. CDRH provides consumers, patients, their caregivers, and providers with understandable and accessible science-based information about the products we oversee. We facilitate medical device innovation by advancing regulatory science, providing industry with predictable, consistent, transparent, and efficient regulatory pathways, and assuring consumer confidence in devices marketed in the United States.